A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy (Q38875321)

7 September 2017

title

A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy (English)

1 reference

7 September 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Peilian Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

Jiangsheng Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

Donghang Yan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

Fang Zeng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

Bowen Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

Shuizhu Wu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

1 June 2015

1 reference

7 September 2017

published in

Chemical Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

issue

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

9567-9570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25971544 AND SRC:MED&resulttype=core&format=json

Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking

11 June 2020

cites work

1 reference

In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.

21 January 2018

1 reference

A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells.

21 January 2018

1 reference

Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin

21 January 2018

1 reference

Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery.

21 January 2018

1 reference

Redox-responsive, core-cross-linked micelles capable of on-demand, concurrent drug release and structure disassembly

21 January 2018

1 reference

Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy.

21 January 2018

1 reference

NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release

21 January 2018

1 reference

Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy.

21 January 2018

1 reference

Polymer micelle with pH-triggered hydrophobic-hydrophilic transition and de-cross-linking process in the core and its application for targeted anticancer drug delivery

21 January 2018

1 reference

A smart polymer for drug delivery sensitive to tumor extracellular pH.

21 January 2018

1 reference

pH-sensitive nano-systems for drug delivery in cancer therapy

21 January 2018

1 reference

A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation

21 January 2018

1 reference

Real-time monitoring of drug release

21 January 2018

1 reference

INDQ/NO, a bioreductively activated nitric oxide prodrug

21 January 2018

1 reference

Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells

21 January 2018

1 reference

A fluorescent probe for investigating the activation of anticancer platinum(IV) prodrugs based on the cisplatin scaffold.

21 January 2018

1 reference

Cell-Specific, Activatable, and Theranostic Prodrug for Dual-Targeted Cancer Imaging and Therapy

21 January 2018

1 reference

An activatable prodrug for the treatment of metastatic tumors.

21 January 2018

1 reference

Gold-Coated Fe3O4 Nanoroses with Five Unique Functions for Cancer Cell Targeting, Imaging and Therapy.

21 January 2018

1 reference

A sensitive, homogeneous fluorescence assay for detection of thymine DNA glycosylase activity based on exonuclease-mediated amplification

21 January 2018

1 reference

Inhibition of dsDNA-templated copper nanoparticles by pyrophosphate as a label-free fluorescent strategy for alkaline phosphatase assay

21 January 2018

1 reference

Prodrug-inspired probes selective to cathepsin B over other cysteine cathepsins

21 January 2018

1 reference

Graphene-mesoporous silica-dispersed palladium nanoparticles-based probe carrier platform for electrocatalytic sensing of telomerase activity at less than single-cell level

21 January 2018

1 reference

New latent fluorophore for DT diaphorase

21 January 2018

1 reference

DT-diaphorase: a target for new anticancer drugs

21 January 2018

1 reference

Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative profluorophore.

21 January 2018

1 reference

Shedding light by cancer redox-human NAD(P)H:quinone oxidoreductase 1 activation of a cloaked fluorescent dye.

21 January 2018

1 reference

Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1

21 January 2018

1 reference

Enzyme-catalyzed activation of anticancer prodrugs

21 January 2018

1 reference